Article Correctness Is Author's Responsibility: New Self-expanding TAVR Prosthesis Does Not Meet Non-Inferiority Compared to SAPIEN 3

The first randomized trial to compare the safety and efficacy of the new ACURATE neo transcatheter heart valve with the SAPIEN 3 TAVR device did not meet non-inferiority in patients with severe aortic stenosis.